Laxxon Medical | WebDisclosure

Switch to English

8301	Sociétés
115073	Mots-clés
55422	Articles
62513	Communiqués

Accueil
Sociétés
Laxxon Medical

COMMUNIQUÉ DE PRESSE

publié le 16/05/2024 à 15:00, il y a 6 mois 5 jours

Laxxon Medical to Showcase LXM.2, a Novel 3D Printed GLP-1 Agonist at BIO 2024
Laxxon Medical will showcase LXM.2, a novel 3D printed GLP-1 agonist, at the 2024 BIO International Convention in San Diego, seeking out-licensing or co-development opportunities

BIO International Convention Laxxon Medical GLP-1 Agonist LXM.2 3D Printed
BRÈVE

publiée le 23/04/2024 à 22:45, il y a 6 mois 27 jours

Laxxon Medical participera au Congrès mondial des médicaments orphelins aux États-Unis 2024

Industrie Pharmaceutique Laxxon Medical Congrès Sur Les Médicaments Orphelins Technologie D'impression 3D Maladie Rare
BRÈVE

publiée le 23/04/2024 à 22:45, il y a 6 mois 27 jours

Laxxon Medical to Engage in World Orphan Drug Congress USA 2024

Pharmaceutical Industry 3D Printing Technology Laxxon Medical Orphan Drug Congress Rare Disease
COMMUNIQUÉ DE PRESSE

publié le 23/04/2024 à 22:40, il y a 6 mois 27 jours

Laxxon Medical to Participate in the World Orphan Drug Congress USA 2024
Laxxon Medical to participate in World Orphan Drug Congress USA 2024. Dr. Catherine Gatza to represent the Company at the event in Boston, Massachusetts. Company leveraging SPID®-Technology for pharmaceutical advancements

Laxxon Medical World Orphan Drug Congress USA 2024 SPID®-Technology Pharmaceutical Advancements Drug Delivery Advancements
BRÈVE

publiée le 28/03/2024 à 13:05, il y a 7 mois 24 jours

Laxxon Medical participera à la 23e conférence annuelle sur la santé virtuelle de Needham

Technologie Pharmaceutique Innovation En Matière De Soins De Santé L'administration De Médicaments Laxxon Medical Conférence Virtuelle Sur La Santé
BRÈVE

publiée le 28/03/2024 à 13:05, il y a 7 mois 24 jours

Laxxon Medical to Join 23rd Annual Needham Virtual Health Conference

Healthcare Innovation Drug Delivery Laxxon Medical Virtual Health Conference Pharmaceutical Technology
COMMUNIQUÉ DE PRESSE

publié le 28/03/2024 à 13:00, il y a 7 mois 24 jours

Laxxon Medical to Participate in 23rd Annual Needham Virtual Health Conference
Laxxon Medical to participate in the 23rd Annual Needham Virtual Health Conference. CEO/Chairman and Chief Strategy Officer will engage with investors. Company focuses on advanced pharmaceuticals with innovative technology

Laxxon Medical Virtual Health Conference Pharma-technology Advanced Pharmaceuticals SPID Technology
COMMUNIQUÉ DE PRESSE

publié le 06/11/2023 à 18:00, il y a 1 année

Laxxon Medical to Attend BIO-Europe Munich 2023
COMMUNIQUÉ DE PRESSE

publié le 17/07/2023 à 15:00, il y a 1 année 4 mois

Laxxon Medical and CU Innovations at Anschutz Medical Campus Announce Strategic Partnership
COMMUNIQUÉ DE PRESSE

publié le 06/07/2023 à 14:42, il y a 1 année 4 mois

3D screen printing technology enables fabrication of oral dosage forms with freely tailorable drug release profiles – technology and concept well suited for mass production

Les Echos

Publié le 21/11/2024 à 06:58, il y a 12 heures 8 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 12 heures 8 minutes

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Publié le 21/11/2024 à 06:58, il y a 12 heures 8 minutes

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Publié le 20/11/2024 à 20:07, il y a 22 heures 59 minutes

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Publié le 20/11/2024 à 19:20, il y a 23 heures 46 minutes

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

Voir tout LES ECHOS COMFI WIRE

Accesswire

Publié le 21/11/2024 à 17:35, il y a 1 heure 31 minutes

1upHealth Ranked Number 43 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500(TM)
Publié le 21/11/2024 à 17:30, il y a 1 heure 36 minutes

SimpliGov and Proof Partner to Offer Online Notarization
Publié le 21/11/2024 à 16:30, il y a 2 heures 36 minutes

The Rise of DINKs: Dual-Income Couples Without Kids Redefine Financial Priorities in America
Publié le 21/11/2024 à 16:01, il y a 3 heures 5 minutes

Career Certified Extends Its Investment in the Fast-Growing Architecture, Engineering, and Construction (AEC) Professionals Market with Acquisition of My Contractors License
Publié le 21/11/2024 à 16:00, il y a 3 heures 6 minutes

Financial Independence Group Announces Exclusive Partnership With Power of Zero and Tax-Free Retirement Expert David McKnight

Voir tout ACCESSWIRE

EQS Group

Publié le 21/11/2024 à 18:36, il y a 30 minutes

Original-Research: Beaconsmind AG (von First Berlin Equity Research GmbH): BUY
Publié le 21/11/2024 à 17:58, il y a 1 heure 8 minutes

Funding Circle Plc: POS-Transaction in Own Shares
Publié le 21/11/2024 à 17:51, il y a 1 heure 14 minutes

LIGHTON announces highly successful IPO on Euronext Growth Paris.
Publié le 21/11/2024 à 17:51, il y a 1 heure 14 minutes

LIGHTON annonce le vif succès de son introduction en Bourse sur Euronext Growth Paris.
Publié le 21/11/2024 à 17:51, il y a 1 heure 15 minutes

2CRSi SA: 2CRSi supplies Exaion, a subsidiary of the EDF Group, with high-performance immersion servers in North America.